Oral Wegovy’s Unique Bottle Sparks Discussion as Experts Explain Its Purpose
A distinctive packaging design in the recently released oral Wegovy weight-loss medication has drawn attention from patients and online…
-
-
Novo Nordisk Oral GLP-1 Pipeline: Advances in Metabolic Therapeutics
Novo Nordisk leads the market in metabolic treatments through its range of injectable drugs. The manufacturer now develops oral…
-
Beyond the Needle: BoomRx Brings Oral GLP-1 Options to Weight Management
BoomRx is pushing the weight-management market in a new direction by expanding access to oral semaglutide and tirzepatide through…
-
Wegovy Goes Oral: Ro Brings the Weight-Loss Pill to Patients Nationwide
Ro has begun rolling out a new option in weight-loss care with the nationwide availability of the Wegovy pill….
-
Weight Loss Reshapes Fat Cells and Restores Metabolic Health, Study Finds
Weight loss may do far more than reduce body weight. New research shows it can actively reshape fat tissue…
-
Oral GLP-1 Orforglipron Helps Patients Maintain Weight Loss After Stopping Injectable GLP-1 Drugs
A new phase 3 trial suggests that the investigational oral GLP-1 drug orforglipron may help people maintain weight loss…
-
Oral Wegovy Steps Into the Spotlight as Early Prescriptions Signal Strong Interest
Novo Nordisk has made an early mark in the U.S. weight-loss market with its new oral version of Wegovy,…
-
Tom Brady Becomes eMed Chief Wellness Officer for GLP-1 Drugs
Seven-time Super Bowl champion Tom Brady is taking on a new role as Chief Wellness Officer at telehealth startup…
